๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

FK-506 and cyclosporin A : immunosuppressive mechanism of action and beyond

โœ Scribed by John J Siekierka; Nolan H Sigal


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
725 KB
Volume
4
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

โœฆ Synopsis


Cyclosporin A and FK-506 are important therapeutic agents that have found widespread use in preventing graft rejection during tissue transplantation. Research efforts aimed at elucidating the molecular mechanism of action of these drugs have, in addition to defining their immunosuppressive functions, led to the identification of two new gene families whose products may function as components of several diverse signal transduction pathways. In the presence of the immunosuppressive drugs, some members of the receptor families interact with the Ca2+/calmodulin-dependent protein phosphatase 2B, also known as calcineurin. Inhibition of phosphatase activity may effect several downstream biochemical processes. In this way, cyclosporin A and FK-506 have proved to be useful probes of signaling events in both lymphocytic and other cell types.


๐Ÿ“œ SIMILAR VOLUMES


Distribution characteristics of immunosu
โœ Kanji Takada; Naohisa Katayama; Akiko Kiriyama; Hisato Usuda ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 781 KB

Using two representative immunosuppressants, FK506 (FK) and cyclosporin A (CyA), of which the mechanism of pharmacological action is the same although there is a great difference in the pharmacological intensity, the distribution characteristics were studied in both in vivo and in vitro experiments

Suppression of B cell activation by cycl
โœ Linda S. Wicker; Robert C. Boltz Jr.; Victoria Matt; Elizabeth A. Nichols; Laure ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 722 KB

## Abstract The effects of the immunosuppressants cyclosporin A (CsA), FK506 and rapamycin have been compared using murine B cells activated with a variety of mitogens. FK506 is a macrolide antibiotic that has been recently shown to inhibit T cell activation by a mechanism that appears similar to t